From Name:
From Email:
To Name:
To Email:

Optional Message:

Akebia sues after CMS removes Auryxia from Medicare Part D coverage

from Healio

Akebia Therapeutics has filed a lawsuit against CMS for rescinding Medicare Part D coverage of the company’s FDA-approved iron drug Auryxia and for the agency’s decision to impose a prior authorization requirement for use of the drug to treat hyperphosphatemia. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063